» Articles » PMID: 17635931

Endocytotic Internalization As a Crucial Factor for the Cytotoxicity of Ribonucleases

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2007 Jul 20
PMID 17635931
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The cytotoxic action of ribonucleases (RNases) requires the interaction of the enzyme with the cellular membrane, its internalization, translocation to the cytosol, and the degradation of ribonucleic acid. The interplay of these processes as well as the role of the thermodynamic and proteolytic stability, the catalytic activity, and the evasion from the intracellular ribonuclease inhibitor (RI) has not yet been fully elucidated. As cytosolic internalization is indispensable for the cytotoxicity of extracellular ribonucleases, we investigated the extent of cytosolic internalization of a cytotoxic, RI-evasive RNase A variant (G88R-RNase A) and of various similarly cytotoxic but RI-sensitive RNase A tandem enzyme variants in comparison to the internalization of the non-cytotoxic and RI-sensitive RNase A. After incubation of K-562 cells with the RNase A variants for 36 h, the internalized amount of RNases was analyzed by rapid cell disruption followed by subcellular fractionation and semiquantitative immunoblotting. The data indicate that an enhanced cellular uptake and an increased entry of the RNases into the cytosol can outweigh the abolishment of catalytic activity by RI. As all RNase A variants proved to be resistant to the proteases present in the different subcellular fractions for more than 100 h, our results suggest that the cytotoxic potency of RNases is determined by an efficient internalization into the cytosol.

Citing Articles

EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells.

Jafary B, Akbarzadeh-Khiavi M, Farzi-Khajeh H, Safary A, Adibkia K Sci Rep. 2025; 15(1):1483.

PMID: 39789190 PMC: 11718297. DOI: 10.1038/s41598-025-85856-9.


Engineering Human Pancreatic RNase 1 as an Immunotherapeutic Agent for Cancer Therapy Through Computational and Experimental Studies.

Nassiri M, Ghovvati S, Gharouni M, Tahmoorespur M, Bahrami A, Dehghani H Protein J. 2023; 43(2):316-332.

PMID: 38145445 DOI: 10.1007/s10930-023-10171-z.


Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections.

Menegazzi M, Gotte G Int J Mol Sci. 2022; 23(12).

PMID: 35742999 PMC: 9223570. DOI: 10.3390/ijms23126556.


Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.

Gotte G, Menegazzi M Front Immunol. 2019; 10:2626.

PMID: 31849926 PMC: 6901985. DOI: 10.3389/fimmu.2019.02626.


Picornavirus RNA is protected from cleavage by ribonuclease during virion uncoating and transfer across cellular and model membranes.

Groppelli E, Levy H, Sun E, Strauss M, Nicol C, Gold S PLoS Pathog. 2017; 13(2):e1006197.

PMID: 28166307 PMC: 5325612. DOI: 10.1371/journal.ppat.1006197.